{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:04:10Z","timestamp":1790370250024,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymgme.2026.110252","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:20:35Z","timestamp":1787923235000},"page":"110252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early detection in action: developing and refining newborn screening for Pompe disease in North Carolina"],"prefix":"10.1016","volume":"149","author":[{"given":"Molly M.","family":"Crenshaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica B.","family":"Nading","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Huggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Krohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeksha","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlee R.","family":"Stiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Percenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dee","family":"Pettit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Shone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin C.","family":"Ferren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Dempsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayleigh","family":"Bright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rehder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110252_bb0005","series-title":"Inborn Metabolic Diseases\u202f: Diagnosis and Treatment","author":"Saudubray","year":"2022"},{"key":"10.1016\/j.ymgme.2026.110252_bb0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110252_bb0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2016.12.004","article-title":"The emerging phenotype of late-onset Pompe disease: a systematic literature review","volume":"120","author":"Chan","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110252_bb0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2022.01.003","article-title":"Early clinical phenotype of late onset Pompe disease: lessons learned from newborn screening","volume":"135","author":"Huggins","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110252_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2026.109762","article-title":"Lessons from late-onset Pompe disease identified by Newborn screening: a systematic review","volume":"147","author":"Boueri","year":"2026","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110252_bb0030","article-title":"An analysis of Pompe newborn screening data: a new prevalence at birth, insight and discussion","volume":"11","author":"Colburn","year":"2023","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110252_bb0035","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41436-020-01038-0","article-title":"Health and economic outcomes of newborn screening for infantile-onset Pompe disease","volume":"23","author":"Richardson","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110252_bb0040","series-title":"Newborn Screening Status for All Disorders","author":"NewSTEPS","year":"2025"},{"key":"10.1016\/j.ymgme.2026.110252_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijns6010009","article-title":"The first year experience of newborn screening for Pompe disease in California","volume":"6","author":"Tang","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2026.110252_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6040089","article-title":"Newborn screening for Pompe disease: Pennsylvania experience","volume":"6","author":"Ficicioglu","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2026.110252_bb0055","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41436-018-0129-y","article-title":"The New York pilot newborn screening program for lysosomal storage diseases: report of the first 65,000 infants","volume":"21","author":"Wasserstein","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110252_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6010004","article-title":"Newborn screening for Pompe disease in Illinois: experience with 684,290 infants","volume":"6","author":"Burton","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2026.110252_bb0065","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1542\/peds.2016-0280C","article-title":"Newborn screening for Pompe disease","volume":"140","author":"Bodamer","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2026.110252_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.109008","article-title":"Digital microfluidic platform for dried blood spot newborn screening of lysosomal storage diseases in Campania region (Italy): findings from the first year pilot project","volume":"144","author":"Scarcella","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110252_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ijns6010011","article-title":"Lessons learned from Pompe disease newborn screening and follow-up","volume":"6","author":"Klug","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2026.110252_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijns11020048","article-title":"Analysis of the effect of demographic variables on lysosomal enzyme activities in the Missouri newborn screening program","volume":"11","author":"Vermette","year":"2025","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2026.110252_bb0085","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1542\/peds.2016-0280D","article-title":"The initial evaluation of patients after positive newborn screening: recommended algorithms leading to a confirmed diagnosis of Pompe disease","volume":"140","author":"Burton","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2026.110252_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ijns6020031","article-title":"Newborn screening for Pompe disease","volume":"6","author":"Sawada","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2026.110252_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2026.110114","article-title":"Over ten years of newborn screening for LSDs in Tuscany (Italy): epidemiology, novel variants, and the pseudodeficiency burden","volume":"148","author":"Malvagia","year":"2026","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110252_bb0100","series-title":"R: A Language and Environment for Statistical Computing","author":"Team, R.C","year":"2024"},{"key":"10.1016\/j.ymgme.2026.110252_bb0105","series-title":"Microsoft Excel","author":"Corporation, M","year":"2024"},{"key":"10.1016\/j.ymgme.2026.110252_bb0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mus.21376","article-title":"Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory","volume":"40","author":"Goldstein","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2026.110252_bb0115","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ymgme.2006.12.006","article-title":"Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots","volume":"90","author":"Kallwass","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110252_bb0120","first-page":"37","article-title":"Diurnal variability of glucose tetrasaccharide (Glc(4)) excretion in patients with glycogen storage disease type III","volume":"58","author":"Young","year":"2021","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ymgme.2026.110252_bb0125","article-title":"Optimizing clinical outcomes: the journey of twins with CRIM-negative infantile-onset Pompe disease on high-dose enzyme replacement therapy and immunomodulation","volume":"41","author":"Fares","year":"2024","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110252_bb0130","article-title":"Optimizing treatment outcomes: immune tolerance induction in Pompe disease patients undergoing enzyme replacement therapy","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymgme.2026.110252_bb0135","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s41436-018-0270-7","article-title":"An immune tolerance approach using transient low-dose methotrexate in the ERT-naive setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease","volume":"21","author":"Kazi","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110252_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2019.04.027","article-title":"The North Carolina experience with mucopolysaccharidosis type I newborn screening","volume":"211","author":"Taylor","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110252_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1001154","article-title":"Development of a clinically validated in vitro functional assay to assess pathogenicity of novel GAA variants in patients with Pompe disease identified via newborn screening","volume":"13","author":"Goomber","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2026.110252_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2025.101604","article-title":"Reduction of false-positive results with biochemical second-tier testing for newborn screening of Pompe disease","volume":"28","author":"Khoja","year":"2026","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110252_bb0155","article-title":"Five years of newborn screening for Pompe, mucopolysaccharidosis type I, Gaucher, and Fabry diseases in Oregon","volume":"43","author":"Viall","year":"2025","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110252_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijns11010016","article-title":"Five-year outcomes of patients with Pompe disease identified by the Pennsylvania newborn screen","volume":"11","author":"Ron","year":"2025","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2026.110252_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6020044","article-title":"A comparative effectiveness study of newborn screening methods for four lysosomal storage disorders","volume":"6","author":"Sanders","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2026.110252_bb0170","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.cca.2021.05.010","article-title":"Galactocerebrosidase activity by liquid-chromatography tandem mass spectrometry for clinical diagnosis of Krabbe disease","volume":"519","author":"Liao","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2026.110252_bb0175","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/clinchem\/hvae043","article-title":"Ultra-performance liquid chromatography-tandem mass spectrometry analysis of urinary oligosaccharides and glycoamino acids for the diagnosis of mucopolysaccharidosis and glycoproteinosis","volume":"70","author":"Wongkittichote","year":"2024","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2026.110252_bb0180","article-title":"Newborn screening for Pompe disease in Italy: long-term results and future challenges","volume":"33","author":"Gragnaniello","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110252_bb0185","article-title":"Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening","volume":"36","author":"Jackson","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110252_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6010001","article-title":"Is newborn screening the ultimate strategy to reduce diagnostic delays in Pompe disease? The parent and patient perspective","volume":"6","author":"Saich","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2026.110252_bb0195","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/jgc4.1615","article-title":"Newborn screening for Pompe disease: parental experiences and follow-up care for a late-onset diagnosis","volume":"31","author":"Prakash","year":"2022","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ymgme.2026.110252_bb0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/ijns6020048","article-title":"Expanding newborn screening for Pompe disease in the United States: the NewSTEPs new disorders implementation project, a resource for new disorder implementation","volume":"6","author":"Hale","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2026.110252_bb0205","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/ajmg.a.36110","article-title":"Timing of diagnosis of patients with Pompe disease: data from the Pompe registry","volume":"161A","author":"Kishnani","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2026.110252_bb0210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pediatrneurol.2025.08.003","article-title":"Navigating the emotional and practical challenges of newborn screening for late-onset Pompe disease: insights from parental perspectives","volume":"172","author":"Boueri","year":"2025","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2026.110252_bb0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ijns6010022","article-title":"A newborn screening, presymptomatically identified infant with late-onset Pompe disease: case report, parental experience, and recommendations","volume":"6","author":"Wang","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2026.110252_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109235","article-title":"Parental psychosocial outcomes after a positive newborn screen for a lysosomal storage disorder","volume":"146","author":"Berrios","year":"2025","journal-title":"Mol. Genet. Metab."}],"updated-by":[{"DOI":"10.1016\/j.ymgme.2026.110259","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:36:17Z","timestamp":1790368577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226005354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1096719226005354"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110252","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early detection in action: developing and refining newborn screening for Pompe disease in North Carolina","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110252"}}